AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| WSH | Ann: Dividend Details - Class A Notes | 23/04/18 | 0 | 39 | |||
|
|||||||
| WSH | Ann: Dividend Details - Class A Notes | 22/03/18 | 0 | 65 | |||
|
|||||||
See All Discussions
ASX News